// May 24, 2023
World Vaccine Congress 2023: Spotlight shines on mRNA and viral vectored technology platforms
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Revised on: January 17, 2023
Impurities found in pharmaceuticals are a cause for concern.